Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 921-923

  Ghannoum, Mahmoud A ^a,b   Elewski, Boni ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Department of Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; DESIPRAMINE; DICLOFENAC; FLUCONAZOLE; FLUTICASONE PROPIONATE; HISTAMINE H2 RECEPTOR AGONIST; TERBINAFINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CHEEK MUCOSA; DRUG EFFECT; ERYTHEMA; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PALATE; PRIORITY JOURNAL; TONGUE;

EID: 0032706804     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.921-923.1999     Document Type: Article

References (22)

1. Barrett-Bee, K., and N. S. Ryder. 1992. Biochemical aspects of ergosterol biosynthesis inhibition, p. 410-436. In J. A. Sutcliffe and N. H. Georgopapadakou (ed.), Emerging targets for antibacterial and antifungal chemotherapy. Chapman and Hall, New York, N.Y.
2. Cox, N. H., and B. Irving. 1993. Cutaneous 'ringworm' lesions of Scopulariapsis brevicaulis. Br. J. Dermatol. 129:726-728.
3. Dennis, M., and I. H. Itkin. 1964. Effectiveness and complications of aerosol dexamethasone phosphate in severe asthma. J. Allergy 35:70-76.
4. Engelkens, H. J. H., and B. Naafs. 1994. Mycetoma. Br. J. Dermatol. 131: 722-723.
5. Fothergill, A. W., I. Leitner, J. G. Meingassner, N. S. Ryder, and M. G. Rinaldi. 1996. Combination antifungal susceptibility testing of terbinafine and the triazoles fluconazole and itraconazole, abstr. E53, p. 91. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Ghannoum, M. A., and L. B. Rice. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev., in press.
7. Lazardi, K., J. A. Urbina, and W. De Souza. 1990. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 34:2097-2105.
8. Leitner, I., J. G. Meingassner, and N. S. Ryder. 1996. Potential of terbinafine for combination with other antimycotics against Candida and Aspergillus, abstr. 472. In Abstracts of Clinical Dermatology 2000.
9. 50 values, and their combination effects. Chemotherapy (Tokyo) 39: 1-8.
10. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Odds, F. C. 1988. Iatrogenic factors that predispose to candidiasis, p. 104-108. In Candida and candidosis, 2nd ed. Bailliere Tindall, London, United Kingdom.
12. Polak, A. 1996. Combination therapy for systemic mycosis. Infection 17:203-209.
13. Redding, S. J., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-247.
14. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, et al. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections. Clin. Infect. Dis. 24:235-247.
15. Rodero, L., R. Vitale, F. Hochenfaller, C. Canteros, and G. Davel. 1996. In vitro activity of terbinafine in combination with triazole drugs against fluconazole resistant Candida species, abstr. E56, p. 91. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Ryder, N. S., and I. Leitner. 1996. Activity of terbinafine against Aspergillus in vitro, in combination with amphotericin B or triazoles, abstr. E54, p. 91. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
17. Ryder, N. S., and B. Favre. 1997. Pharmacokinetics of terbinafine. Rev. Contemp. Pharmacother. 8:289-297.
18. Seelig, M. S. 1966. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol. Rev. 30:442-459.
19. Seelig, M. S. 1966. The role of antibiotics in the pathogenesis of Candida infections. Am. J. Med. 40:887-917.
20. Seelig, M. S. 1968. The rationale for preventing anti-bacterial-induced fungal overgrowth. Med. Times 96:689-710.
21. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1988. Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizoirypanum) cruzi. Antimicrob. Agents Chemother. 32:1237-1242.
22. Zegarelli, E. V., and A. H. Kutscher. 1964. Oral moniliasis following intraoral topical corticosteroid therapy. J. Oral Ther. 1:304-307.